Stack 2012.
Methods | Parallel group design. Method of randomisation not stated. Method of analysis not stated. Treated at home for 12 hours over 4 weeks. Assessed at baseline, 4 weeks, 8 weeks and 12 weeks. Assessors blinded for all outcomes with the exception of forward reaches (FR). |
|
Participants | 24 participants in physio group, 23 participants in control group. 8 drop‐outs in physio group, 4 in control group. Participants median age 75 years (physio), 74 years (control). Male/female ratio 17/7 (physio), 18/5 (control). Hoehn and Yahr 1.3 (physio), 1.7 (control). Duration of condition (median) 8 years (physio), 7 (control). Inclusion criteria: Parkinson's disease as per UK Brain Bank criteria, willing and able to take part in intervention, willing and able to complete outcome measures, score of at least 8/12 on the Middlesex elderly assessment of mental state, Hoehn and Yahr I‐IV, self report chair transfers as excessively slow or requiring much effort, assistance or repeated attempts or associated with a previous fall. |
|
Interventions | Physio: Home‐based physiotherapy programme focused on chair transfers. Supervised exercises to enhance hip and knee extensor strength and trunk stability and flexibility. Teaching and learning movement strategies for safer and easier standing and sitting. Verbal cueing. Control: No physiotherapy. |
|
Outcomes | PAS chair transfer. Sit‐to‐stand time. SAS score. SS‐180 turn time. Forward reach. UPDRS posture. HR‐QOL. Assessed in "ON" phase. |
|
Notes | Data reported as median (IQR). | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Eligibility Criteria | Low risk | Inclusion criteria stated. |
Randomisation Method | Unclear risk | Method not stated. |
Concealment of Allocation | Unclear risk | Method of randomisation not stated. |
Similarity at Baseline | Low risk | Baseline characteristics similar in both arms. |
Withdrawals Described | High risk | 26% withdrawals. |
Intention To Treat Analysis | Unclear risk | Method of analysis not stated. |
Cointerventions Constant | Unclear risk | Drug therapy not described. |
Blinded Assessors | Low risk | Assessors blinded except for functional reach measurement. |